Related Experiment Video
Updated: Sep 17, 2025

19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
86.4K
Prenatal Substance Exposure and Positive Developmental Delay Screening Among Patients in Foster Care
Lauren Q Malthaner1,2, Jill D McLeigh3, Gregory Knell4
1Department of Epidemiology, University of Texas Health Science Center School of Public Health, Dallas, TX.
Summary
Children in foster care with prenatal substance exposure (PSE) face higher risks of developmental delays. Those with PSE and prematurity experience the greatest risk, highlighting the need for targeted screening.
Area of Science:
- Pediatrics
- Developmental Psychology
- Public Health
Background:
- Prenatal substance exposure (PSE) is linked to adverse birth and neurodevelopmental outcomes.
- Children in foster care exhibit higher rates of PSE and developmental delays than the general population.
Purpose of the Study:
- To investigate developmental delay screening differences in foster care children with and without PSE.
- To identify specific risk factors, including prematurity, interacting with PSE.
Main Methods:
- Retrospective analysis of medical records for 975 foster care children (2018-2021).
- Cox proportional hazards regression used for developmental delay screening analysis.
- Controlled for sex, race, ethnicity, prematurity, and caregiver type; examined PSE interactions.
Main Results:
- 60.4% of children had PSE; 62.6% screened positive for developmental delay.
- PSE without prematurity increased delay screening hazard by 1.14 times.
- PSE with prematurity increased delay screening hazard by 2.01 times.
Conclusions:
- Foster care children with PSE are at increased risk for developmental delays.
- The combination of PSE and prematurity significantly elevates this risk.
- Consideration of PSE and prematurity interaction is crucial for effective developmental delay screening.
More Related Videos
Related Concept Videos
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Attention-Deficit/Hyperactivity Disorder
310
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
310

